PIER 88 INVESTMENT PARTNERS LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
PIER 88 INVESTMENT PARTNERS LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q1 2024$84,792
-30.2%
26,415
+6.5%
0.02%
-32.3%
Q4 2023$121,496
-70.9%
24,795
-67.6%
0.03%
-70.2%
Q3 2023$416,898
-13.3%
76,495
+6.8%
0.10%
-12.6%
Q2 2023$480,604
-24.0%
71,6250.0%0.12%
-22.2%
Q1 2023$632,449
+44.7%
71,625
+25.2%
0.15%
+44.3%
Q4 2022$437,046
+7.4%
57,2050.0%0.11%
+9.3%
Q3 2022$407,000
-8.9%
57,205
+3.5%
0.10%
-7.6%
Q2 2022$447,000
+49.0%
55,265
+155.8%
0.10%
-2.8%
Q1 2022$300,000
-67.1%
21,605
-33.5%
0.11%
-44.0%
Q4 2021$911,000
+45.5%
32,475
+76.3%
0.19%
+2.7%
Q3 2021$626,000
-46.7%
18,425
-35.9%
0.19%
-44.4%
Q2 2021$1,175,000
+73.0%
28,762
+70.6%
0.34%
+47.0%
Q1 2021$679,000
-36.1%
16,862
-6.2%
0.23%
-32.7%
Q4 2020$1,062,000
-11.4%
17,972
-27.1%
0.34%
-5.8%
Q3 2020$1,198,000
+91.7%
24,642
+90.9%
0.36%
+103.9%
Q2 2020$625,00012,9100.18%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2020
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,687,665$5,417,4055.10%
Rubric Capital Management LP 10,500,000$33,705,0001.00%
Triatomic Management LP 98,555$316,3620.59%
Pier Capital, LLC 1,103,441$3,542,0460.49%
Newtyn Management, LLC 623,690$2,002,0450.40%
VIKING GLOBAL INVESTORS LP 29,993,708$96,279,8030.36%
Matrix Capital Management Company, LP 11,572,590$37,148,0140.34%
Tejara Capital Ltd 269,014$863,5350.32%
Aristotle Atlantic Partners, LLC 2,992,563$9,606,1270.31%
DDD Partners, LLC 739,739$2,374,5620.29%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders